Koss-Olinger Consulting’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$467K Sell
10,116
-250
-2% -$10.1K 0.04% 95
2026
Q1
$343K Hold
10,366
– – 0.03% 188
2025
Q4
$339K Hold
10,366
– – 0.03% 206
2025
Q3
$112K Hold
10,366
– – 0.01% 303
2025
Q2
$112K Sell
10,366
-1
-0% -$13 0.01% 306
2025
Q1
$192K Hold
10,367
– – 0.02% 298
2024
Q4
$171K Hold
10,367
– – 0.02% 170
2024
Q3
$145K Hold
10,367
– – 0.01% 262
2024
Q2
$75K Buy
+10,367
New +$70.9K 0.01% 256
2024
Q1
– Sell
-10,367
Closed -$71K – 63
2023
Q4
$71K Hold
10,367
– – 0.01% 309
2023
Q3
$52K Hold
10,367
– – 0.01% 271
2023
Q2
$95K Hold
10,367
– – 0.01% 273
2023
Q1
$98K Hold
10,367
– – 0.01% 253
2022
Q4
$103K Hold
10,367
– – 0.01% 231
2022
Q3
$124K Hold
10,367
– – 0.02% 216
2022
Q2
$85K Hold
10,367
– – 0.02% 179
2022
Q1
$82K Hold
10,367
– – 0.01% 199
2021
Q4
$97K Buy
10,367
+250
+2% +$3K 0.01% 205
2021
Q3
$160K Hold
10,117
– – 0.03% 211
2021
Q2
$219K Hold
10,117
– – 0.03% 214
2021
Q1
$205K Buy
+10,117
New +$200K 0.03% 209

Other funds holding AXGN

Koss-Olinger Consulting's AXGN Position: Q2 2026 in Review

Koss-Olinger Consulting reduced its Axogen (AXGN) stake by 2.4% in Q2 2026, selling an estimated $10.1K and leaving 10,116 shares worth $467K. The position accounts for 0.04% of the portfolio, ranked #95.

Koss-Olinger Consulting first reported a position in AXGN in Q1 2021 and has held it in 21 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Koss-Olinger Consulting held 10,116 shares of Axogen worth $467K as of Q2 2026.
  • Koss-Olinger Consulting sold 250 Axogen shares in Q2 2026, an estimated $10.1K.
  • Axogen made up 0.04% of Koss-Olinger Consulting's portfolio in Q2 2026, its #95 holding.
  • Koss-Olinger Consulting first reported a position in Axogen in Q1 2021 and has held it in 21 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Koss-Olinger Consulting's 13F filing for Q2 2026, filed 10 Aug 2026.